nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—atherosclerosis	0.434	1	CbGaD
Oxaprozin—CYP2C9—Rosuvastatin—atherosclerosis	0.0694	0.267	CbGbCtD
Oxaprozin—CYP2C9—Simvastatin—atherosclerosis	0.0645	0.248	CbGbCtD
Oxaprozin—CYP2C9—Pravastatin—atherosclerosis	0.0632	0.243	CbGbCtD
Oxaprozin—CYP2C9—Lovastatin—atherosclerosis	0.0632	0.243	CbGbCtD
Oxaprozin—PTGS2—leg—atherosclerosis	0.00327	0.138	CbGeAlD
Oxaprozin—PTGS2—hindlimb—atherosclerosis	0.00292	0.123	CbGeAlD
Oxaprozin—PTGS2—appendage—atherosclerosis	0.00251	0.106	CbGeAlD
Oxaprozin—PTGS1—artery—atherosclerosis	0.00187	0.079	CbGeAlD
Oxaprozin—Antazoline—HRH1—atherosclerosis	0.00182	0.478	CrCbGaD
Oxaprozin—PTGS2—artery—atherosclerosis	0.00179	0.0755	CbGeAlD
Oxaprozin—PTGS1—endothelium—atherosclerosis	0.00158	0.0667	CbGeAlD
Oxaprozin—PTGS2—endothelium—atherosclerosis	0.00151	0.0638	CbGeAlD
Oxaprozin—PTGS1—blood vessel—atherosclerosis	0.00146	0.0616	CbGeAlD
Oxaprozin—PTGS2—blood vessel—atherosclerosis	0.0014	0.0588	CbGeAlD
Oxaprozin—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000792	0.00419	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000789	0.00417	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000765	0.00404	CcSEcCtD
Oxaprozin—Jaundice—Ezetimibe—atherosclerosis	0.000764	0.00404	CcSEcCtD
Oxaprozin—Arrhythmia—Rosuvastatin—atherosclerosis	0.000756	0.004	CcSEcCtD
Oxaprozin—Eosinophilia—Pravastatin—atherosclerosis	0.00075	0.00396	CcSEcCtD
Oxaprozin—Sinusitis—Lovastatin—atherosclerosis	0.00075	0.00396	CcSEcCtD
Oxaprozin—PTGS1—connective tissue—atherosclerosis	0.000749	0.0316	CbGeAlD
Oxaprozin—Pancreatitis—Pravastatin—atherosclerosis	0.000743	0.00393	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000741	0.00392	CcSEcCtD
Oxaprozin—Sweating increased—Pravastatin—atherosclerosis	0.000738	0.0039	CcSEcCtD
Oxaprozin—Sinusitis—Ezetimibe—atherosclerosis	0.000735	0.00389	CcSEcCtD
Oxaprozin—Jaundice—Simvastatin—atherosclerosis	0.000728	0.00385	CcSEcCtD
Oxaprozin—Flatulence—Rosuvastatin—atherosclerosis	0.000726	0.00384	CcSEcCtD
Oxaprozin—Hepatitis—Lovastatin—atherosclerosis	0.000717	0.00379	CcSEcCtD
Oxaprozin—PTGS2—connective tissue—atherosclerosis	0.000715	0.0302	CbGeAlD
Oxaprozin—CYP2C9—cardiovascular system—atherosclerosis	0.000713	0.0301	CbGeAlD
Oxaprozin—Dysuria—Pravastatin—atherosclerosis	0.000709	0.00374	CcSEcCtD
Oxaprozin—Hepatitis—Ezetimibe—atherosclerosis	0.000703	0.00372	CcSEcCtD
Oxaprozin—Sinusitis—Simvastatin—atherosclerosis	0.000701	0.00371	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000692	0.00366	CcSEcCtD
Oxaprozin—Erythema multiforme—Lovastatin—atherosclerosis	0.000678	0.00358	CcSEcCtD
Oxaprozin—Angioedema—Rosuvastatin—atherosclerosis	0.000673	0.00356	CcSEcCtD
Oxaprozin—Hepatitis—Simvastatin—atherosclerosis	0.000671	0.00355	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00067	0.00354	CcSEcCtD
Oxaprozin—Stomatitis—Niacin—atherosclerosis	0.000669	0.00353	CcSEcCtD
Oxaprozin—Jaundice—Niacin—atherosclerosis	0.000669	0.00353	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000666	0.00352	CcSEcCtD
Oxaprozin—Erythema multiforme—Ezetimibe—atherosclerosis	0.000665	0.00352	CcSEcCtD
Oxaprozin—Myocardial infarction—Pravastatin—atherosclerosis	0.000662	0.0035	CcSEcCtD
Oxaprozin—Jaundice—Pravastatin—atherosclerosis	0.000659	0.00348	CcSEcCtD
Oxaprozin—PTGS1—cardiovascular system—atherosclerosis	0.000651	0.0275	CbGeAlD
Oxaprozin—Erythema multiforme—Simvastatin—atherosclerosis	0.000634	0.00335	CcSEcCtD
Oxaprozin—Sinusitis—Pravastatin—atherosclerosis	0.000634	0.00335	CcSEcCtD
Oxaprozin—Alopecia—Lovastatin—atherosclerosis	0.000634	0.00335	CcSEcCtD
Oxaprozin—PTGS2—cardiovascular system—atherosclerosis	0.000623	0.0262	CbGeAlD
Oxaprozin—Alopecia—Ezetimibe—atherosclerosis	0.000622	0.00329	CcSEcCtD
Oxaprozin—Haemoglobin—Niacin—atherosclerosis	0.000619	0.00327	CcSEcCtD
Oxaprozin—Haemorrhage—Niacin—atherosclerosis	0.000616	0.00326	CcSEcCtD
Oxaprozin—Hepatitis—Niacin—atherosclerosis	0.000616	0.00326	CcSEcCtD
Oxaprozin—Flatulence—Lovastatin—atherosclerosis	0.000615	0.00325	CcSEcCtD
Oxaprozin—Dysgeusia—Lovastatin—atherosclerosis	0.000611	0.00323	CcSEcCtD
Oxaprozin—Hepatitis—Pravastatin—atherosclerosis	0.000606	0.00321	CcSEcCtD
Oxaprozin—Confusional state—Rosuvastatin—atherosclerosis	0.000606	0.0032	CcSEcCtD
Oxaprozin—Flatulence—Ezetimibe—atherosclerosis	0.000603	0.00319	CcSEcCtD
Oxaprozin—Infection—Rosuvastatin—atherosclerosis	0.000597	0.00316	CcSEcCtD
Oxaprozin—Alopecia—Simvastatin—atherosclerosis	0.000593	0.00313	CcSEcCtD
Oxaprozin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000589	0.00311	CcSEcCtD
Oxaprozin—Vision blurred—Lovastatin—atherosclerosis	0.000588	0.00311	CcSEcCtD
Oxaprozin—Tremor—Lovastatin—atherosclerosis	0.000585	0.00309	CcSEcCtD
Oxaprozin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000579	0.00306	CcSEcCtD
Oxaprozin—Flatulence—Simvastatin—atherosclerosis	0.000575	0.00304	CcSEcCtD
Oxaprozin—Tinnitus—Niacin—atherosclerosis	0.000574	0.00304	CcSEcCtD
Oxaprozin—PTGS1—adipose tissue—atherosclerosis	0.000574	0.0242	CbGeAlD
Oxaprozin—Erythema multiforme—Pravastatin—atherosclerosis	0.000573	0.00303	CcSEcCtD
Oxaprozin—Dysgeusia—Simvastatin—atherosclerosis	0.000572	0.00302	CcSEcCtD
Oxaprozin—Angioedema—Lovastatin—atherosclerosis	0.00057	0.00301	CcSEcCtD
Oxaprozin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000568	0.003	CcSEcCtD
Oxaprozin—Anaemia—Ezetimibe—atherosclerosis	0.000566	0.00299	CcSEcCtD
Oxaprozin—Tinnitus—Pravastatin—atherosclerosis	0.000565	0.00299	CcSEcCtD
Oxaprozin—Malaise—Lovastatin—atherosclerosis	0.000563	0.00298	CcSEcCtD
Oxaprozin—Vertigo—Lovastatin—atherosclerosis	0.000561	0.00296	CcSEcCtD
Oxaprozin—Angioedema—Ezetimibe—atherosclerosis	0.00056	0.00296	CcSEcCtD
Oxaprozin—Leukopenia—Lovastatin—atherosclerosis	0.000559	0.00295	CcSEcCtD
Oxaprozin—Malaise—Ezetimibe—atherosclerosis	0.000552	0.00292	CcSEcCtD
Oxaprozin—Vision blurred—Simvastatin—atherosclerosis	0.00055	0.00291	CcSEcCtD
Oxaprozin—Arrhythmia—Niacin—atherosclerosis	0.00055	0.00291	CcSEcCtD
Oxaprozin—PTGS2—adipose tissue—atherosclerosis	0.000549	0.0231	CbGeAlD
Oxaprozin—Tremor—Simvastatin—atherosclerosis	0.000547	0.00289	CcSEcCtD
Oxaprozin—Alopecia—Niacin—atherosclerosis	0.000544	0.00288	CcSEcCtD
Oxaprozin—Insomnia—Rosuvastatin—atherosclerosis	0.000544	0.00287	CcSEcCtD
Oxaprozin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000542	0.00286	CcSEcCtD
Oxaprozin—Arrhythmia—Pravastatin—atherosclerosis	0.000542	0.00286	CcSEcCtD
Oxaprozin—Palpitations—Ezetimibe—atherosclerosis	0.000541	0.00286	CcSEcCtD
Oxaprozin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00054	0.00285	CcSEcCtD
Oxaprozin—Anaemia—Simvastatin—atherosclerosis	0.00054	0.00285	CcSEcCtD
Oxaprozin—Alopecia—Pravastatin—atherosclerosis	0.000536	0.00283	CcSEcCtD
Oxaprozin—Angioedema—Simvastatin—atherosclerosis	0.000534	0.00282	CcSEcCtD
Oxaprozin—Anxiety—Lovastatin—atherosclerosis	0.00053	0.0028	CcSEcCtD
Oxaprozin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000529	0.0028	CcSEcCtD
Oxaprozin—Hypertension—Ezetimibe—atherosclerosis	0.000529	0.00279	CcSEcCtD
Oxaprozin—Flatulence—Niacin—atherosclerosis	0.000528	0.00279	CcSEcCtD
Oxaprozin—Malaise—Simvastatin—atherosclerosis	0.000527	0.00278	CcSEcCtD
Oxaprozin—Tension—Niacin—atherosclerosis	0.000526	0.00278	CcSEcCtD
Oxaprozin—Discomfort—Lovastatin—atherosclerosis	0.000525	0.00278	CcSEcCtD
Oxaprozin—Vertigo—Simvastatin—atherosclerosis	0.000525	0.00277	CcSEcCtD
Oxaprozin—Leukopenia—Simvastatin—atherosclerosis	0.000523	0.00276	CcSEcCtD
Oxaprozin—Nervousness—Niacin—atherosclerosis	0.000521	0.00275	CcSEcCtD
Oxaprozin—Flatulence—Pravastatin—atherosclerosis	0.00052	0.00275	CcSEcCtD
Oxaprozin—Dry mouth—Lovastatin—atherosclerosis	0.00052	0.00275	CcSEcCtD
Oxaprozin—Tension—Pravastatin—atherosclerosis	0.000518	0.00274	CcSEcCtD
Oxaprozin—Dysgeusia—Pravastatin—atherosclerosis	0.000517	0.00273	CcSEcCtD
Oxaprozin—Discomfort—Ezetimibe—atherosclerosis	0.000515	0.00272	CcSEcCtD
Oxaprozin—Constipation—Rosuvastatin—atherosclerosis	0.000514	0.00272	CcSEcCtD
Oxaprozin—Confusional state—Lovastatin—atherosclerosis	0.000514	0.00272	CcSEcCtD
Oxaprozin—Nervousness—Pravastatin—atherosclerosis	0.000513	0.00271	CcSEcCtD
Oxaprozin—Dry mouth—Ezetimibe—atherosclerosis	0.00051	0.00269	CcSEcCtD
Oxaprozin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00051	0.00269	CcSEcCtD
Oxaprozin—Infection—Lovastatin—atherosclerosis	0.000506	0.00268	CcSEcCtD
Oxaprozin—Vision blurred—Niacin—atherosclerosis	0.000505	0.00267	CcSEcCtD
Oxaprozin—Confusional state—Ezetimibe—atherosclerosis	0.000504	0.00266	CcSEcCtD
Oxaprozin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.0005	0.00264	CcSEcCtD
Oxaprozin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000499	0.00264	CcSEcCtD
Oxaprozin—Vision blurred—Pravastatin—atherosclerosis	0.000498	0.00263	CcSEcCtD
Oxaprozin—Infection—Ezetimibe—atherosclerosis	0.000496	0.00262	CcSEcCtD
Oxaprozin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000495	0.00262	CcSEcCtD
Oxaprozin—Anxiety—Simvastatin—atherosclerosis	0.000495	0.00262	CcSEcCtD
Oxaprozin—Tremor—Pravastatin—atherosclerosis	0.000495	0.00261	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000492	0.0026	CcSEcCtD
Oxaprozin—Discomfort—Simvastatin—atherosclerosis	0.000491	0.0026	CcSEcCtD
Oxaprozin—Angioedema—Niacin—atherosclerosis	0.00049	0.00259	CcSEcCtD
Oxaprozin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00049	0.00259	CcSEcCtD
Oxaprozin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000489	0.00259	CcSEcCtD
Oxaprozin—Anaemia—Pravastatin—atherosclerosis	0.000488	0.00258	CcSEcCtD
Oxaprozin—Anorexia—Lovastatin—atherosclerosis	0.000486	0.00257	CcSEcCtD
Oxaprozin—Angioedema—Pravastatin—atherosclerosis	0.000482	0.00255	CcSEcCtD
Oxaprozin—Vertigo—Niacin—atherosclerosis	0.000482	0.00255	CcSEcCtD
Oxaprozin—Syncope—Niacin—atherosclerosis	0.000481	0.00254	CcSEcCtD
Oxaprozin—Confusional state—Simvastatin—atherosclerosis	0.000481	0.00254	CcSEcCtD
Oxaprozin—Leukopenia—Niacin—atherosclerosis	0.00048	0.00254	CcSEcCtD
Oxaprozin—Urticaria—Rosuvastatin—atherosclerosis	0.000478	0.00252	CcSEcCtD
Oxaprozin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000477	0.00252	CcSEcCtD
Oxaprozin—Oedema—Simvastatin—atherosclerosis	0.000477	0.00252	CcSEcCtD
Oxaprozin—Malaise—Pravastatin—atherosclerosis	0.000476	0.00252	CcSEcCtD
Oxaprozin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000475	0.00251	CcSEcCtD
Oxaprozin—Vertigo—Pravastatin—atherosclerosis	0.000474	0.00251	CcSEcCtD
Oxaprozin—Palpitations—Niacin—atherosclerosis	0.000474	0.0025	CcSEcCtD
Oxaprozin—Infection—Simvastatin—atherosclerosis	0.000473	0.0025	CcSEcCtD
Oxaprozin—Leukopenia—Pravastatin—atherosclerosis	0.000473	0.0025	CcSEcCtD
Oxaprozin—Diphenhydramine—HRH1—atherosclerosis	0.000472	0.124	CrCbGaD
Oxaprozin—Loss of consciousness—Niacin—atherosclerosis	0.000471	0.00249	CcSEcCtD
Oxaprozin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000467	0.00247	CcSEcCtD
Oxaprozin—Insomnia—Lovastatin—atherosclerosis	0.000461	0.00244	CcSEcCtD
Oxaprozin—Paraesthesia—Lovastatin—atherosclerosis	0.000458	0.00242	CcSEcCtD
Oxaprozin—Hypertension—Pravastatin—atherosclerosis	0.000456	0.00241	CcSEcCtD
Oxaprozin—Anorexia—Simvastatin—atherosclerosis	0.000454	0.0024	CcSEcCtD
Oxaprozin—Dyspnoea—Lovastatin—atherosclerosis	0.000454	0.0024	CcSEcCtD
Oxaprozin—Insomnia—Ezetimibe—atherosclerosis	0.000452	0.00239	CcSEcCtD
Oxaprozin—Paraesthesia—Ezetimibe—atherosclerosis	0.000449	0.00237	CcSEcCtD
Oxaprozin—Dyspepsia—Lovastatin—atherosclerosis	0.000449	0.00237	CcSEcCtD
Oxaprozin—Anxiety—Pravastatin—atherosclerosis	0.000448	0.00237	CcSEcCtD
Oxaprozin—Dry mouth—Niacin—atherosclerosis	0.000446	0.00236	CcSEcCtD
Oxaprozin—Dyspnoea—Ezetimibe—atherosclerosis	0.000446	0.00235	CcSEcCtD
Oxaprozin—Discomfort—Pravastatin—atherosclerosis	0.000444	0.00235	CcSEcCtD
Oxaprozin—Decreased appetite—Lovastatin—atherosclerosis	0.000443	0.00234	CcSEcCtD
Oxaprozin—CYP2C9—liver—atherosclerosis	0.000441	0.0186	CbGeAlD
Oxaprozin—Dyspepsia—Ezetimibe—atherosclerosis	0.00044	0.00233	CcSEcCtD
Oxaprozin—Anaphylactic shock—Niacin—atherosclerosis	0.000438	0.00231	CcSEcCtD
Oxaprozin—Oedema—Niacin—atherosclerosis	0.000438	0.00231	CcSEcCtD
Oxaprozin—Constipation—Lovastatin—atherosclerosis	0.000436	0.0023	CcSEcCtD
Oxaprozin—Confusional state—Pravastatin—atherosclerosis	0.000434	0.0023	CcSEcCtD
Oxaprozin—Decreased appetite—Ezetimibe—atherosclerosis	0.000434	0.0023	CcSEcCtD
Oxaprozin—Asthenia—Rosuvastatin—atherosclerosis	0.000431	0.00228	CcSEcCtD
Oxaprozin—Insomnia—Simvastatin—atherosclerosis	0.000431	0.00228	CcSEcCtD
Oxaprozin—Oedema—Pravastatin—atherosclerosis	0.000431	0.00228	CcSEcCtD
Oxaprozin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000431	0.00228	CcSEcCtD
Oxaprozin—Shock—Niacin—atherosclerosis	0.000431	0.00228	CcSEcCtD
Oxaprozin—Infection—Pravastatin—atherosclerosis	0.000428	0.00226	CcSEcCtD
Oxaprozin—Paraesthesia—Simvastatin—atherosclerosis	0.000428	0.00226	CcSEcCtD
Oxaprozin—Constipation—Ezetimibe—atherosclerosis	0.000427	0.00226	CcSEcCtD
Oxaprozin—Tachycardia—Niacin—atherosclerosis	0.000427	0.00226	CcSEcCtD
Oxaprozin—Pruritus—Rosuvastatin—atherosclerosis	0.000425	0.00225	CcSEcCtD
Oxaprozin—Dyspnoea—Simvastatin—atherosclerosis	0.000425	0.00225	CcSEcCtD
Oxaprozin—Hyperhidrosis—Niacin—atherosclerosis	0.000423	0.00224	CcSEcCtD
Oxaprozin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000422	0.00223	CcSEcCtD
Oxaprozin—Feeling abnormal—Lovastatin—atherosclerosis	0.00042	0.00222	CcSEcCtD
Oxaprozin—Dyspepsia—Simvastatin—atherosclerosis	0.00042	0.00222	CcSEcCtD
Oxaprozin—Anorexia—Niacin—atherosclerosis	0.000417	0.0022	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000417	0.0022	CcSEcCtD
Oxaprozin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000417	0.0022	CcSEcCtD
Oxaprozin—Decreased appetite—Simvastatin—atherosclerosis	0.000414	0.00219	CcSEcCtD
Oxaprozin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000412	0.00218	CcSEcCtD
Oxaprozin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000411	0.00217	CcSEcCtD
Oxaprozin—Anorexia—Pravastatin—atherosclerosis	0.000411	0.00217	CcSEcCtD
Oxaprozin—Hypotension—Niacin—atherosclerosis	0.000409	0.00216	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000409	0.00216	CcSEcCtD
Oxaprozin—Constipation—Simvastatin—atherosclerosis	0.000408	0.00215	CcSEcCtD
Oxaprozin—Urticaria—Lovastatin—atherosclerosis	0.000405	0.00214	CcSEcCtD
Oxaprozin—Body temperature increased—Lovastatin—atherosclerosis	0.000403	0.00213	CcSEcCtD
Oxaprozin—Abdominal pain—Lovastatin—atherosclerosis	0.000403	0.00213	CcSEcCtD
Oxaprozin—Dizziness—Rosuvastatin—atherosclerosis	0.000398	0.0021	CcSEcCtD
Oxaprozin—Urticaria—Ezetimibe—atherosclerosis	0.000397	0.0021	CcSEcCtD
Oxaprozin—Insomnia—Niacin—atherosclerosis	0.000396	0.00209	CcSEcCtD
Oxaprozin—Abdominal pain—Ezetimibe—atherosclerosis	0.000395	0.00209	CcSEcCtD
Oxaprozin—Body temperature increased—Ezetimibe—atherosclerosis	0.000395	0.00209	CcSEcCtD
Oxaprozin—Paraesthesia—Niacin—atherosclerosis	0.000393	0.00208	CcSEcCtD
Oxaprozin—Feeling abnormal—Simvastatin—atherosclerosis	0.000393	0.00208	CcSEcCtD
Oxaprozin—Fenbufen—PTGS2—atherosclerosis	0.000391	0.103	CrCbGaD
Oxaprozin—Dyspnoea—Niacin—atherosclerosis	0.00039	0.00206	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00039	0.00206	CcSEcCtD
Oxaprozin—Insomnia—Pravastatin—atherosclerosis	0.00039	0.00206	CcSEcCtD
Oxaprozin—Somnolence—Niacin—atherosclerosis	0.000389	0.00206	CcSEcCtD
Oxaprozin—Paraesthesia—Pravastatin—atherosclerosis	0.000387	0.00204	CcSEcCtD
Oxaprozin—Dyspepsia—Niacin—atherosclerosis	0.000385	0.00204	CcSEcCtD
Oxaprozin—PTGS2—liver—atherosclerosis	0.000385	0.0162	CbGeAlD
Oxaprozin—Dyspnoea—Pravastatin—atherosclerosis	0.000384	0.00203	CcSEcCtD
Oxaprozin—Decreased appetite—Niacin—atherosclerosis	0.00038	0.00201	CcSEcCtD
Oxaprozin—Dyspepsia—Pravastatin—atherosclerosis	0.000379	0.002	CcSEcCtD
Oxaprozin—Rash—Rosuvastatin—atherosclerosis	0.000379	0.002	CcSEcCtD
Oxaprozin—Dermatitis—Rosuvastatin—atherosclerosis	0.000379	0.002	CcSEcCtD
Oxaprozin—Urticaria—Simvastatin—atherosclerosis	0.000379	0.002	CcSEcCtD
Oxaprozin—Abdominal pain—Simvastatin—atherosclerosis	0.000377	0.00199	CcSEcCtD
Oxaprozin—Body temperature increased—Simvastatin—atherosclerosis	0.000377	0.00199	CcSEcCtD
Oxaprozin—Headache—Rosuvastatin—atherosclerosis	0.000377	0.00199	CcSEcCtD
Oxaprozin—Decreased appetite—Pravastatin—atherosclerosis	0.000375	0.00198	CcSEcCtD
Oxaprozin—Constipation—Pravastatin—atherosclerosis	0.000368	0.00195	CcSEcCtD
Oxaprozin—Asthenia—Lovastatin—atherosclerosis	0.000366	0.00193	CcSEcCtD
Oxaprozin—Pruritus—Lovastatin—atherosclerosis	0.00036	0.00191	CcSEcCtD
Oxaprozin—Asthenia—Ezetimibe—atherosclerosis	0.000359	0.0019	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Niacin—atherosclerosis	0.000358	0.00189	CcSEcCtD
Oxaprozin—Nausea—Rosuvastatin—atherosclerosis	0.000357	0.00189	CcSEcCtD
Oxaprozin—Feeling abnormal—Pravastatin—atherosclerosis	0.000355	0.00188	CcSEcCtD
Oxaprozin—Pruritus—Ezetimibe—atherosclerosis	0.000354	0.00187	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000352	0.00186	CcSEcCtD
Oxaprozin—Diarrhoea—Lovastatin—atherosclerosis	0.000349	0.00184	CcSEcCtD
Oxaprozin—Urticaria—Niacin—atherosclerosis	0.000348	0.00184	CcSEcCtD
Oxaprozin—Abdominal pain—Niacin—atherosclerosis	0.000346	0.00183	CcSEcCtD
Oxaprozin—Body temperature increased—Niacin—atherosclerosis	0.000346	0.00183	CcSEcCtD
Oxaprozin—Urticaria—Pravastatin—atherosclerosis	0.000342	0.00181	CcSEcCtD
Oxaprozin—Asthenia—Simvastatin—atherosclerosis	0.000342	0.00181	CcSEcCtD
Oxaprozin—Diarrhoea—Ezetimibe—atherosclerosis	0.000342	0.00181	CcSEcCtD
Oxaprozin—Abdominal pain—Pravastatin—atherosclerosis	0.000341	0.0018	CcSEcCtD
Oxaprozin—Body temperature increased—Pravastatin—atherosclerosis	0.000341	0.0018	CcSEcCtD
Oxaprozin—Pruritus—Simvastatin—atherosclerosis	0.000337	0.00178	CcSEcCtD
Oxaprozin—Dizziness—Lovastatin—atherosclerosis	0.000337	0.00178	CcSEcCtD
Oxaprozin—Dizziness—Ezetimibe—atherosclerosis	0.00033	0.00175	CcSEcCtD
Oxaprozin—Diarrhoea—Simvastatin—atherosclerosis	0.000326	0.00172	CcSEcCtD
Oxaprozin—Vomiting—Lovastatin—atherosclerosis	0.000324	0.00171	CcSEcCtD
Oxaprozin—Rash—Lovastatin—atherosclerosis	0.000321	0.0017	CcSEcCtD
Oxaprozin—Dermatitis—Lovastatin—atherosclerosis	0.000321	0.0017	CcSEcCtD
Oxaprozin—Headache—Lovastatin—atherosclerosis	0.000319	0.00169	CcSEcCtD
Oxaprozin—Vomiting—Ezetimibe—atherosclerosis	0.000318	0.00168	CcSEcCtD
Oxaprozin—Dizziness—Simvastatin—atherosclerosis	0.000315	0.00167	CcSEcCtD
Oxaprozin—Rash—Ezetimibe—atherosclerosis	0.000315	0.00167	CcSEcCtD
Oxaprozin—Dermatitis—Ezetimibe—atherosclerosis	0.000315	0.00166	CcSEcCtD
Oxaprozin—Asthenia—Niacin—atherosclerosis	0.000314	0.00166	CcSEcCtD
Oxaprozin—Headache—Ezetimibe—atherosclerosis	0.000313	0.00165	CcSEcCtD
Oxaprozin—Pruritus—Niacin—atherosclerosis	0.00031	0.00164	CcSEcCtD
Oxaprozin—Asthenia—Pravastatin—atherosclerosis	0.000309	0.00163	CcSEcCtD
Oxaprozin—Pruritus—Pravastatin—atherosclerosis	0.000305	0.00161	CcSEcCtD
Oxaprozin—Vomiting—Simvastatin—atherosclerosis	0.000303	0.0016	CcSEcCtD
Oxaprozin—Nausea—Lovastatin—atherosclerosis	0.000303	0.0016	CcSEcCtD
Oxaprozin—Rash—Simvastatin—atherosclerosis	0.000301	0.00159	CcSEcCtD
Oxaprozin—Dermatitis—Simvastatin—atherosclerosis	0.0003	0.00159	CcSEcCtD
Oxaprozin—Diarrhoea—Niacin—atherosclerosis	0.000299	0.00158	CcSEcCtD
Oxaprozin—Headache—Simvastatin—atherosclerosis	0.000299	0.00158	CcSEcCtD
Oxaprozin—Nausea—Ezetimibe—atherosclerosis	0.000297	0.00157	CcSEcCtD
Oxaprozin—Diarrhoea—Pravastatin—atherosclerosis	0.000295	0.00156	CcSEcCtD
Oxaprozin—Dizziness—Niacin—atherosclerosis	0.000289	0.00153	CcSEcCtD
Oxaprozin—Dizziness—Pravastatin—atherosclerosis	0.000285	0.00151	CcSEcCtD
Oxaprozin—Nausea—Simvastatin—atherosclerosis	0.000283	0.0015	CcSEcCtD
Oxaprozin—Vomiting—Niacin—atherosclerosis	0.000278	0.00147	CcSEcCtD
Oxaprozin—Rash—Niacin—atherosclerosis	0.000276	0.00146	CcSEcCtD
Oxaprozin—Dermatitis—Niacin—atherosclerosis	0.000276	0.00146	CcSEcCtD
Oxaprozin—Headache—Niacin—atherosclerosis	0.000274	0.00145	CcSEcCtD
Oxaprozin—Vomiting—Pravastatin—atherosclerosis	0.000274	0.00145	CcSEcCtD
Oxaprozin—Rash—Pravastatin—atherosclerosis	0.000272	0.00144	CcSEcCtD
Oxaprozin—Dermatitis—Pravastatin—atherosclerosis	0.000271	0.00143	CcSEcCtD
Oxaprozin—Headache—Pravastatin—atherosclerosis	0.00027	0.00143	CcSEcCtD
Oxaprozin—Nausea—Niacin—atherosclerosis	0.00026	0.00137	CcSEcCtD
Oxaprozin—Nausea—Pravastatin—atherosclerosis	0.000256	0.00135	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—atherosclerosis	0.000225	0.0592	CrCbGaD
Oxaprozin—Phenprocoumon—ALB—atherosclerosis	0.000216	0.0569	CrCbGaD
Oxaprozin—Warfarin—ALB—atherosclerosis	0.000192	0.0504	CrCbGaD
Oxaprozin—Flurbiprofen—PTGS2—atherosclerosis	0.000183	0.0483	CrCbGaD
Oxaprozin—Flurbiprofen—ALB—atherosclerosis	0.000163	0.043	CrCbGaD
Oxaprozin—Phenytoin—ALB—atherosclerosis	0.000139	0.0366	CrCbGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	7.45e-05	0.000841	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	7.45e-05	0.00084	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	7.33e-05	0.000827	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLTP—atherosclerosis	7.31e-05	0.000825	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	7.26e-05	0.000819	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—atherosclerosis	7.25e-05	0.000818	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	7.16e-05	0.000808	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	7.14e-05	0.000805	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	7.01e-05	0.00079	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	7.01e-05	0.00079	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	6.88e-05	0.000776	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	6.86e-05	0.000774	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.77e-05	0.000764	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	6.76e-05	0.000762	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.73e-05	0.00076	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.69e-05	0.000755	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.64e-05	0.000749	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.54e-05	0.000737	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCG8—atherosclerosis	6.34e-05	0.000715	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LTA4H—atherosclerosis	6.34e-05	0.000715	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCG1—atherosclerosis	6.31e-05	0.000712	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	6.26e-05	0.000706	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	6.24e-05	0.000704	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	6.23e-05	0.000703	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	6.04e-05	0.000682	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—FABP4—atherosclerosis	5.94e-05	0.00067	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LCAT—atherosclerosis	5.94e-05	0.00067	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	5.92e-05	0.000668	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	5.92e-05	0.000668	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	5.92e-05	0.000668	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	5.92e-05	0.000668	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.91e-05	0.000667	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	5.85e-05	0.00066	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOA4—atherosclerosis	5.83e-05	0.000657	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	5.76e-05	0.00065	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP7A1—atherosclerosis	5.72e-05	0.000646	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.65e-05	0.000637	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	5.64e-05	0.000637	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOA4—atherosclerosis	5.52e-05	0.000623	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.45e-05	0.000615	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.41e-05	0.000611	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP27A1—atherosclerosis	5.29e-05	0.000597	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	5.27e-05	0.000594	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.21e-05	0.000588	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.21e-05	0.000588	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	5.15e-05	0.000581	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.08e-05	0.000573	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.03e-05	0.000568	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALOX5AP—atherosclerosis	5.01e-05	0.000566	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALOX15—atherosclerosis	5.01e-05	0.000566	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOA2—atherosclerosis	5.01e-05	0.000566	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLA2G2A—atherosclerosis	5.01e-05	0.000566	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCG1—atherosclerosis	5.01e-05	0.000565	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCG5—atherosclerosis	4.95e-05	0.000559	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.95e-05	0.000558	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	4.94e-05	0.000557	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.85e-05	0.000547	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLTP—atherosclerosis	4.84e-05	0.000546	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LPA—atherosclerosis	4.78e-05	0.00054	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOA2—atherosclerosis	4.75e-05	0.000536	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LCAT—atherosclerosis	4.71e-05	0.000532	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—FABP4—atherosclerosis	4.71e-05	0.000532	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—BGN—atherosclerosis	4.63e-05	0.000523	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOA4—atherosclerosis	4.62e-05	0.000522	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.6e-05	0.000519	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOA5—atherosclerosis	4.59e-05	0.000517	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	4.55e-05	0.000514	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP7A1—atherosclerosis	4.54e-05	0.000513	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.49e-05	0.000506	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.48e-05	0.000505	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.46e-05	0.000503	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.46e-05	0.000503	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.43e-05	0.0005	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PLA2G1B—atherosclerosis	4.41e-05	0.000498	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—BGN—atherosclerosis	4.39e-05	0.000495	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.37e-05	0.000492	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.33e-05	0.000488	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.33e-05	0.000488	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.32e-05	0.000488	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.32e-05	0.000487	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALOX5—atherosclerosis	4.26e-05	0.000481	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.24e-05	0.000478	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP27A1—atherosclerosis	4.2e-05	0.000474	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG8—atherosclerosis	4.2e-05	0.000474	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LTA4H—atherosclerosis	4.2e-05	0.000474	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.14e-05	0.000468	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.13e-05	0.000466	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.11e-05	0.000464	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.03e-05	0.000455	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOA2—atherosclerosis	3.98e-05	0.000449	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALOX5AP—atherosclerosis	3.98e-05	0.000449	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLA2G2A—atherosclerosis	3.98e-05	0.000449	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALOX15—atherosclerosis	3.98e-05	0.000449	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.94e-05	0.000444	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCG5—atherosclerosis	3.93e-05	0.000444	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.93e-05	0.000443	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.91e-05	0.000442	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.84e-05	0.000433	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CST3—atherosclerosis	3.83e-05	0.000432	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NAMPT—atherosclerosis	3.82e-05	0.000431	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.8e-05	0.000429	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LIPC—atherosclerosis	3.8e-05	0.000429	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LPA—atherosclerosis	3.8e-05	0.000428	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOC3—atherosclerosis	3.78e-05	0.000426	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LDLR—atherosclerosis	3.75e-05	0.000424	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—BGN—atherosclerosis	3.68e-05	0.000415	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CETP—atherosclerosis	3.67e-05	0.000414	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.65e-05	0.000412	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOA5—atherosclerosis	3.64e-05	0.000411	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NAMPT—atherosclerosis	3.63e-05	0.000409	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOC3—atherosclerosis	3.58e-05	0.000404	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LDLR—atherosclerosis	3.56e-05	0.000401	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.54e-05	0.000399	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SCARB1—atherosclerosis	3.51e-05	0.000396	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PLA2G1B—atherosclerosis	3.5e-05	0.000395	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.49e-05	0.000394	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.47e-05	0.000391	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HSPA1B—atherosclerosis	3.44e-05	0.000388	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.43e-05	0.000387	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.43e-05	0.000386	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.42e-05	0.000386	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALOX5—atherosclerosis	3.38e-05	0.000382	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NCF1—atherosclerosis	3.33e-05	0.000376	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG1—atherosclerosis	3.32e-05	0.000374	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HMGCR—atherosclerosis	3.32e-05	0.000374	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CYBA—atherosclerosis	3.13e-05	0.000353	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.13e-05	0.000353	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LCAT—atherosclerosis	3.12e-05	0.000352	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—FABP4—atherosclerosis	3.12e-05	0.000352	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PARP1—atherosclerosis	3.06e-05	0.000346	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOA4—atherosclerosis	3.06e-05	0.000346	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NAMPT—atherosclerosis	3.04e-05	0.000343	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.02e-05	0.000341	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LIPC—atherosclerosis	3.02e-05	0.00034	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP7A1—atherosclerosis	3.01e-05	0.000339	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOC3—atherosclerosis	3e-05	0.000338	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.99e-05	0.000337	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LDLR—atherosclerosis	2.98e-05	0.000336	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ABCA1—atherosclerosis	2.96e-05	0.000333	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CETP—atherosclerosis	2.91e-05	0.000328	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.87e-05	0.000323	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.86e-05	0.000322	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SCARB1—atherosclerosis	2.79e-05	0.000314	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.78e-05	0.000314	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.74e-05	0.000309	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.71e-05	0.000306	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.67e-05	0.000301	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOA2—atherosclerosis	2.64e-05	0.000297	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.64e-05	0.000297	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.64e-05	0.000297	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.64e-05	0.000297	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HMGCR—atherosclerosis	2.63e-05	0.000297	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.6e-05	0.000294	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.6e-05	0.000293	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HMOX1—atherosclerosis	2.54e-05	0.000286	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LPA—atherosclerosis	2.51e-05	0.000284	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—BGN—atherosclerosis	2.44e-05	0.000275	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOB—atherosclerosis	2.43e-05	0.000274	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.42e-05	0.000273	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOA5—atherosclerosis	2.41e-05	0.000272	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GSTM1—atherosclerosis	2.36e-05	0.000267	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ABCA1—atherosclerosis	2.35e-05	0.000265	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.34e-05	0.000264	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.32e-05	0.000262	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LPL—atherosclerosis	2.32e-05	0.000262	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOB—atherosclerosis	2.3e-05	0.00026	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.29e-05	0.000259	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.27e-05	0.000257	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.27e-05	0.000256	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GPX1—atherosclerosis	2.26e-05	0.000255	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.24e-05	0.000253	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CD36—atherosclerosis	2.2e-05	0.000249	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—LPL—atherosclerosis	2.2e-05	0.000248	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRKCG—atherosclerosis	2.14e-05	0.000241	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—atherosclerosis	2.09e-05	0.000236	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.07e-05	0.000234	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARA—atherosclerosis	2.05e-05	0.000231	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HMOX1—atherosclerosis	2.01e-05	0.000227	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.01e-05	0.000227	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2e-05	0.000226	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LIPC—atherosclerosis	2e-05	0.000225	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOC3—atherosclerosis	1.99e-05	0.000224	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AGT—atherosclerosis	1.98e-05	0.000224	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—atherosclerosis	1.98e-05	0.000223	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LDLR—atherosclerosis	1.97e-05	0.000223	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOE—atherosclerosis	1.94e-05	0.000219	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOB—atherosclerosis	1.93e-05	0.000218	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CETP—atherosclerosis	1.93e-05	0.000217	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PDGFB—atherosclerosis	1.93e-05	0.000217	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CAV1—atherosclerosis	1.93e-05	0.000217	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—APOA1—atherosclerosis	1.92e-05	0.000217	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GSTM1—atherosclerosis	1.88e-05	0.000212	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.85e-05	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOE—atherosclerosis	1.84e-05	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LPL—atherosclerosis	1.84e-05	0.000208	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—CAV1—atherosclerosis	1.83e-05	0.000206	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—APOA1—atherosclerosis	1.82e-05	0.000206	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.8e-05	0.000203	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GPX1—atherosclerosis	1.8e-05	0.000203	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.75e-05	0.000198	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CD36—atherosclerosis	1.75e-05	0.000197	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.74e-05	0.000197	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS2—atherosclerosis	1.72e-05	0.000194	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARG—atherosclerosis	1.69e-05	0.000191	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—INS—atherosclerosis	1.66e-05	0.000187	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—atherosclerosis	1.66e-05	0.000187	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARA—atherosclerosis	1.63e-05	0.000183	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AGT—atherosclerosis	1.58e-05	0.000178	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—INS—atherosclerosis	1.57e-05	0.000178	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.57e-05	0.000177	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.55e-05	0.000175	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOE—atherosclerosis	1.54e-05	0.000174	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CAV1—atherosclerosis	1.53e-05	0.000173	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—APOA1—atherosclerosis	1.53e-05	0.000172	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ALB—atherosclerosis	1.52e-05	0.000172	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NOS3—atherosclerosis	1.46e-05	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SERPINE1—atherosclerosis	1.45e-05	0.000163	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.39e-05	0.000157	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NOS3—atherosclerosis	1.38e-05	0.000156	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARG—atherosclerosis	1.34e-05	0.000152	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.33e-05	0.00015	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PTGS2—atherosclerosis	1.33e-05	0.00015	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—INS—atherosclerosis	1.32e-05	0.000149	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOB—atherosclerosis	1.28e-05	0.000144	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.24e-05	0.00014	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LPL—atherosclerosis	1.22e-05	0.000138	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ALB—atherosclerosis	1.21e-05	0.000136	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GPX1—atherosclerosis	1.19e-05	0.000134	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CD36—atherosclerosis	1.16e-05	0.000131	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NOS3—atherosclerosis	1.16e-05	0.00013	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.1e-05	0.000124	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARA—atherosclerosis	1.08e-05	0.000122	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AGT—atherosclerosis	1.04e-05	0.000118	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOE—atherosclerosis	1.02e-05	0.000115	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CAV1—atherosclerosis	1.01e-05	0.000114	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—APOA1—atherosclerosis	1.01e-05	0.000114	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—STAT3—atherosclerosis	9.85e-06	0.000111	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MAPK3—atherosclerosis	9.41e-06	0.000106	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	9.22e-06	0.000104	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TGFB1—atherosclerosis	9.13e-06	0.000103	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARG—atherosclerosis	8.9e-06	0.0001	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—INS—atherosclerosis	8.73e-06	9.85e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ALB—atherosclerosis	8e-06	9.03e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NOS3—atherosclerosis	7.66e-06	8.64e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PTGS2—atherosclerosis	7e-06	7.9e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—atherosclerosis	6.88e-06	7.76e-05	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKT1—atherosclerosis	6.69e-06	7.55e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT1—atherosclerosis	6.35e-06	7.16e-05	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKT1—atherosclerosis	5.31e-06	6e-05	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKT1—atherosclerosis	3.52e-06	3.97e-05	CbGpPWpGaD
